MedTrace Logo

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

NCT05598008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2025-12-23

No results posted yet for this study

Summary

This study is to investigate the effects of GLP-1 analogues (combined with lifestyle interventions in comparison to lifestyle interventions only) on sexual desire, mood, quality of life, the reproductive axis, retinal vessel diameters, physical fitness (and semen, for men only) in overweight or obese men and women.

Conditions

  • Sexual Desire

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Bettina Winzeler, Dr. med. · Endocrinology, Diabetes and Metabolism, University Hospital Basel

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-25
Primary Completion
2025-10-24
Completion
2025-10-24

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05598008 on ClinicalTrials.gov